NCT04150419

Brief Summary

Hyper-vigilance, focusing, avoidance are part of the vocabulary used by the clinician who deals with chronic pain. These notions refer to the functioning and dysfunction of so-called "selective" attention. These "selective attentional biases" are believed to be responsible, in part, for the development and maintenance of negative pain-related thoughts (such as catastrophic thoughts), inappropriate behaviours (such as inactivity and fear of movement) and unpleasant emotions (such as stress or anger). In addition, they would also be a powerful indicator of the onset of post-operative pain and could limit the effectiveness of therapeutic management. Therapeutically, attention bias can be "managed" through attentional re-training techniques (ABMs) that teach patients to direct their attention differently. These techniques have been widely validated in anxious or addictive populations but have never been used to date in chronic pain patients. This home-based attention bias management (e-retraining) would represent, for chronic pain patients, an additional tool aimed not only at reducing their pain but also at achieving other associated factors such as anxiety, stress, catastrophic thoughts, avoidance behaviours and quality of life.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2019

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 4, 2019

Completed
1.9 years until next milestone

Study Start

First participant enrolled

October 15, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2022

Completed
Last Updated

December 19, 2022

Status Verified

December 1, 2022

Enrollment Period

1.1 years

First QC Date

October 17, 2019

Last Update Submit

December 15, 2022

Conditions

Keywords

Attentional bias modification trainingchronic pelvi-perinal pain.

Outcome Measures

Primary Outcomes (1)

  • To evaluate the effectiveness of a therapeutic program for attentional re-training on the painful feelings of patients with chronic pelvic-perineal pain.

    Variation in pain assessed from the numerical scale. The Numerical Pain Rating Scale measures the perception of pain intensity with an eleven-point numerical scale. The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain).

    3 months

Study Arms (3)

G1

EXPERIMENTAL
Other: Group 1

G2

EXPERIMENTAL
Other: Group 2

G3

ACTIVE COMPARATOR
Other: Group 3 (control group)

Interventions

Group 1OTHER

Attentional training to avoid threatening, negative or pain-related information.

G1
Group 2OTHER

Attention training for vigilance for positive emotional information.

G2

Neutral attentional training (control group).

G3

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic pain patients, i.e., chronic pain that has been ongoing for more than 3 months.
  • Patient follow-up in the urology department of the University Hospital of Nantes
  • Age between 18 and 65
  • Good understanding of French, able to read and write.
  • Serve correctly and painlessly with both hands
  • Affiliated with a social security system
  • Signed consent
  • With internet access.

You may not qualify if:

  • Current and unstable psychiatric (mood disorders, anxiety disorders) and addictive (substance use disorders, alcoholic or otherwise, excluding nicotine) disorders.
  • Does not use both hands properly and painlessly
  • Depression (BDI-II ≤18)
  • Patient under guardianship, curatorship or judicial protection
  • Pregnant or breastfeeding woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Nantes

Nantes, 44400, France

Location

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Virginie Quistrebert-Davanne, PhD

    Nantes University Hospital Nantes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2019

First Posted

November 4, 2019

Study Start

October 15, 2021

Primary Completion

December 6, 2022

Study Completion

December 6, 2022

Last Updated

December 19, 2022

Record last verified: 2022-12

Locations